SCHEMBL29495196

SCHEMBL29495196

COC(=O)c1cc(-n2ccnc2)ccc1N

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.62
HDAC1 Q13547 1/20 0.50
CYP11B1 P15538 1/20 0.48
CYP11B2 P19099 1/20 0.48
MAPT P10636 6/20 0.48
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 3/20 0.48
GAA P10253 2/20 0.48
HSD17B10 Q99714 2/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
CYP3A4 P08684 1/20 0.48
BAZ2B Q9UIF8 1/20 0.48
LMNA P02545 2/20 0.46
GLA P06280 1/20 0.46
MAPK8 P45983 1/20 0.44
MAPK10 P53779 1/20 0.44
ADH5 P11766 2/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26865606 1.00 HTT (0.62) HTTHDAC1CYP11B1CYP11B2MAPT
SCHEMBL26614109 0.89 HTT (0.62) HTTHDAC1CYP11B1CYP11B2MAPT
SCHEMBL28722512 0.84 HTT (0.55) HTTHDAC1CYP11B1CYP11B2MAPT
SCHEMBL27480025 0.84 HTT (0.62) HTTCYP11B1CYP11B2MAPTALDH1A1
SCHEMBL26614180 0.83 ADH5 (0.54) HTTHDAC1CYP11B1CYP11B2MAPT
SCHEMBL8425351 0.83 MAPT (0.51) HTTHDAC1CYP11B1CYP11B2MAPT
SCHEMBL1239741 0.81 HTT (0.62) HTTCYP11B1CYP11B2MAPTALDH1A1
SCHEMBL26865466 0.80 MAPT (0.61) HTTCYP11B1CYP11B2MAPTALDH1A1
SCHEMBL29495258 0.80 MAPT (0.61) HTTCYP11B1CYP11B2MAPTALDH1A1
SCHEMBL26614095 0.77 MAPT (0.61) HTTCYP11B1CYP11B2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423753-B Heterobicyclic amides as CD38 inhibitors 里邦医疗公司 2024-09-17 CN disclosed
CN-114423753-A Heterobicyclic amides as CD38 inhibitors 里邦医疗公司 2022-04-29 CN disclosed